RQ Biotechnology Ltd.

GSK has asked the European Medicines Agency to fast track its planned EU marketing application for belantamab mafodotin, the company’s multiple myeloma treatment that was approved in the EU and the U

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Biogen’s Pact With AbCellera Will Focus

Most big pharma players have put COVID-19 behind them when it comes to R&D but AstraZeneca PLC 's continuing efforts to develop next-generation antibodies for people who do not respond adequately to

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. New Vertex/CRISPR Pact Centers On Gene-